2021-08-12T12:45:55-05:00 2020-09-30 346565596 Ernst & Young LLP 200 Clarendon Street Boston MA 02116 990 2019-10-01 043554536 Dana-Farber Children's Hospital Cancer Care Inc DANA 8887324662 450 Brookline Avenue BP418 Boston MA 02215 Doug Vanderslice Treasurer 6173556000 2021-08-10 1 Mike A Cincotta P01595811 6172662000 2019 2022-09-23 18:48:47Z Dana-FarberBoston Children's Cancer and Blood and Disorders Center David A Williams MD 450 Brookline Avenue BP418 Boston MA 02215 0 0 X http://www.danafarberbostonchildrens.org/ X 2000 MA To oversee, coordinate and support the Pediatric Oncology Programs at Boston Children's Hospital and Dana-Farber Cancer Institute, Inc. 8 6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 289757 335633 0 0 0 249700 250000 539457 585633 -539457 -585633 0 0 0 0 0 0 X To oversee, coordinate and support the Pediatric Oncology Programs at Boston Children's Hospital and Dana-Farber Cancer Institute, Inc. 0 0 585633 0 0 Dana-Farber/Children's Hospital Cancer Care, Inc. ("DF/CHCC") is a Massachusetts charitable corporation organized on December 14, 2000, whose members are The Children's Hospital Corporation ("Children's") and Dana-Farber Cancer Institute, Inc. ("Dana-Farber"). Its primary purpose is to oversee, coordinate and support the Pediatric Oncology Program (the "Joint Program"). It also, formalizes the pediatric oncology partnership that has existed between Dana-Farber and Children's since 1947.The Joint Program, which is the largest pediatric oncology program in New England and one of the most active in the country, treats more than 2,000 children and adolescents each year. It includes a 20-bed oncology unit, a 13-bed stem cell transplantation unit and an outpatient facility that offers multiple cancer care clinics each week. A team of pediatric oncologists and specially trained and certified oncology nurses from both institutions provides care. Patients requiring round-the-clock care are treated at Children's, while outpatient visits are scheduled at Dana-Farber's Jimmy Fund Clinic. Pediatric experts from more than 30 subspecialty areas at Children's provide supplementary care, as needed, and family support specialists, including counselors, child life specialists, social workers, resource specialists and chaplains from a variety of faiths, are always available.DF/CHCC continues to expand its Home Hydration program which minimizes a patient's time in the hospital by delivering post-chemotherapy hydration through a portable pump. This has not only allowed patients to maintain a more normal schedule, but it has also minimized healthcare costs by saving hundreds of inpatient days. For patients with hard to treat neuroblastoma, DF/CHCC continues to manage a therapeutic metaiodobenzylguanidine(MIBG) treatment program, an advanced therapy that was not previously available in Massachusetts. The Joint Program also focuses on researching and implementing new cancer treatments that improve outcomes and quality of life for its young patients. The team offers an average of 60 clinical trials investigating new therapies for all forms of childhood cancer. Many of these trials are founded on basic research findings from laboratory studies completed at Children's and Dana-Farber. DF/CHCC continues to grow its clinical research by integrating the world class basicresearch being done in cancer and blood diseases within a translational infrastructure in Pediatric Hematology/Oncology. In 2010, our researchers opened an exciting gene therapy protocol for patients with SCID-X1 that uses a novel self-inactivating (SIN) vector.DF/CHCC educates future generations of pediatric hematologists/oncologists through one of the nation's largest and most prestigious fellowship programs. Its clinical and research teams continue to foster collaboration by actively presenting their innovative research in key hematologic/oncologic organizations such as the American Society of Hematology and the American Society of Pediatric Hematology Oncology.Through the David B. Perini, Jr. Quality of Life Clinic and the Stop and Shop Family Pediatric Neuro-Oncology Outcomes Clinic, the Joint Program provides access to long-term care for childhood cancer survivors. Clinicians deliver medical care, such as genetic counseling and secondary cancer screenings, and conduct research studies focused on developing more effective, less toxic approaches by understanding late-effects of today's treatments. 585633 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 8 6 0 0 0 0 1 1 1 1 1 0 0 0 0 0 0 0 0 0 MA X Doug Vanderslice - Treasurer 6173556000 300 Longwood Avenue Boston MA 02215 X Sandra Fenwick Trustee 1.00 55.00 X 0 3006745 74520 Laurie Glimcher MD Trustee 1.00 50.00 X 0 1751115 298313 Doug Vanderslice Treasurer 1.00 55.00 X 0 1494018 68621 Scott Armstrong MD President 1.00 50.00 X 0 710927 68484 Lisa Diller MD Chief Medical Officer 1.00 50.00 X 0 489849 46820 Sharon Herrick Esq Clerk 1.00 50.00 X 0 257874 51783 Gary Fleisher MD Trustee 1.00 1.00 X 0 0 0 Stephen Karp Trustee 1.00 5.00 X 0 0 0 AJ Janower Trustee 1.00 1.00 X 0 0 0 Karen Linde Packman Trustee 1.00 1.00 X 0 0 0 Robert Smith Trustee 1.00 1.00 X 0 0 0 Beth Terrana Trustee 1.00 1.00 X 0 0 0 0 7710528 608541 0 0 1 0 0 0 0 0 0 260665 260665 74968 74968 250000 250000 585633 585633 0 0 0 0 0 0 X 0 0 0 0 X -585633 585633 X X 0 0 0 X X 2 Children's Hospital Corporation 042774441 3 1 292817 0 Dana-Farber Cancer Institute Inc 042263040 7 1 292816 0 2 585633 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 0 Sandra Fenwick Trustee 0 1346647 0 1100000 0 560098 0 28000 0 46520 0 3081265 0 0 Laurie Glimcher MD Trustee 0 1205381 0 414966 0 130768 0 285196 0 13117 0 2049428 0 0 Doug Vanderslice Treasurer 0 792869 0 396900 0 304249 0 22400 0 46221 0 1562639 0 0 Scott Armstrong MD President 0 570268 0 98851 0 41808 0 39555 0 28929 0 779411 0 0 Lisa Diller MD Chief Medical Officer 0 395294 0 75213 0 19342 0 39555 0 7265 0 536669 0 0 Sharon Herrick Esq Clerk 0 234652 0 22842 0 380 0 21130 0 30653 0 309657 0 0 Part I, Line 4b Children's Hospital Corporation and Dana-Farber Cancer Institute, related organizations, made contributions to the supplemental non-qualified retirement plan for the individuals listed below. Contribution amounts are generally based on a percentage of compensation. Participants of the supplemental executive retirement plan are fully vested. All payments with respect to a participant's separation from service will be made in a single sum following the separation from service unless participant has elected to receive the accrued interest portion of his or her account in three annual installments. Contributions were for Children's Hospital Corporation or Dana-Farber Cancer Institute employee benefits and not for Dana-Farber/Children's Hospital Cancer Care, Inc. Trustee or Officer of the Board services and/or responsibilities. Sandra Fenwick, received in 2019, a contribution of $516,000. Lisa Diller, MD, received in 2019, a contribution of $14,986. Doug Vanderslice, received in 2019, a contribution of $206,411. Laurie Glimcher, MD, received in 2019, a contribution of $116,290. Scott Armstrong, MD, received in 2019, a contribution of $37,079. Form 990, Part VI, Section A, line 6 The Members of the Corporation are Children's Hospital Corporation and Dana-Farber Cancer Institute, Inc., each acting through its Board of Trustees. Form 990, Part VI, Section A, line 7a Children's Hospital Corporation and Dana-Farber Cancer Institute, Inc. are Members of the organization. Each Member appoints half the Trustees. Form 990, Part VI, Section A, line 7b Prior to voting on any of the matters described in paragraphs (a) through (k) below, each Trustee entitled to vote shall consult with the designated officer of the Member who appointed him or her. Dana-Farber Cancer Institute, Inc.'s designated officer is its president, and The Children's Hospital Corporation's designated officer is its chief operating officer. The Trustees appointed by a Member may delegate to one or more of their number the responsibility for consulting with the designated officer of the Member, so long as the substance of the designated officer's views on the matter in question are communicated to the other Trustees prior to the vote. Either prior to or after any such vote, each designated officer of a Member may waive his or her right to be consulted on the matter in question. The affirmative vote of at least two-thirds of the Trustees entitled to vote shall be required for: (a) capital and operating budgets, and substantial unbudgeted expenditures; (b) the election and removal of officers listed; (c) fundraising and marketing programs; (d) merger, consolidation, joint venture or affiliation; (e) sale, lease, exchange, gift or other disposition of substantial assets or operations; (f) amendment to the Charter or Bylaws; (g) engagement of accountants, consultants or lawyers; (h) lending or borrowing funds, or guaranteeing the obligation of any person or entity to repay a loan; (i) granting a security interest in any asset of the organization; (j) creation of any subsidiary; and (k) purchase or lease of real estate, or substantial tangible personal property. Form 990, Part VI, Section B, line 11b The Form 990 tax return was prepared by the Children's Hospital staff and reviewed by management, along with the outside accounting firm of Ernst & Young. Form 990, Part VI, Section B Policies, Question 12a, 13 & 14 Dana-Farber / Children's Hospital Cancer Care, Inc. is a collaboration of two separate 501(c)(3) organizations - Dana-Farber Cancer Institute, Inc. and Children's Hospital Corporation. The organization does not have its own separate policy. Each entity follows their own conflict of interest, whistle blower and document retention/destruction policies. Thus, the organization is subject to the policies for both Dana-Farber Cancer Institute, Inc. and Children's Hospital Corporation. Form 990, Part VI, Section B, line 15 Dana-Farber / Children's Hospital Cancer Care, Inc. does not have any employees. The salary and benefits that are recorded on this tax return as an expense to Dana-Farber / Children's Hospital Cancer Care, Inc. are expenses to this entity for tax purposes, but the salaries are paid out of the individual's respective institutions for which they are employed. Thus Children's Hospital Corporation employees are paid by Children's Hospital Corporation and Dana-Farber Cancer Institute, Inc. employees are paid by Dana-Farber Cancer Institute, Inc. Form 990, Part VI, Section C, line 19 The organization does not have its own separate conflict of interest policy nor compliance manual. Each entity follows their own conflict of interest policy and compliance manual. Children's Hospital Corporation posts its Code of Conduct (which incorporates the Conflict of Interest Policy) and its Compliance Manual (which includes a summary of the Conflict of Interest Policy) on its external website and these are also available from the Compliance Office or the Office of General Counsel. Dana-Farber Cancer Institute,Inc. posts its Code of Conduct (which incorporates the Conflict of Interest Policy) and its Compliance Manual (which includes a summary of the Conflict of Interest Policy) on its external website and these are also available from the Human Resources Department, Compliance Office or the Office of General Counsel. Governing documents are not posted publicly but are available from the organization upon request and are also filed with the Massachusetts Secretary of State, where they are available to the public. Financial statements available upon request. Form 990, Part VII, Section A The individuals, who have compensation from related organizations, listed in Column E, spend the remainder of their full time hours working for Children's Medical Center and its other affiliates or for Dana-Farber Cancer Institute, Inc. Form 990, Part XI, line 9: Transfer of expenses paid by Children's Hospital & Dana Farber Cancer Inst. 585,633. Form 990, Part XII, Financial Statements & Reporting, Question 2a & 2b Both members, Children's Hospital Corporation and Dana-Farber Cancer Institute, Inc. have audited financial statements. Further this organization does not meet Massachusetts' threshold for requiring a review or audit of the financial statements. Children's Hospital Corporation 300 Longwood Avenue Boston MA 02115 042774441 Pediatric Hospital MA 501(c)(3) 3 - Hospital Children's Medical Center Corporation 0 Dana-Farber Cancer Institute Inc 450 Brookline Avenue BP418 Boston MA 02215 042263040 Cancer Care Research MA 501(c)(3) 7 - 170b1Avi N/A 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0